Literatur
-
1
Dahlöf B, Sever P S, Poulter N R. et al .
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac OutcomesTrial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet.
2005;
366
895-906
-
2
UK Prospective Diabetes Study Group .
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39.
BMJ.
1998;
317
713-720
-
3
Middeke M.
Die Entwicklung der Hypertonieformen und eine Neubewertung antihypertensiver Substanzen.
Dtsch Med Wochenschr.
2006;
131
1449-1451
Prof. Dr. med. Martin Middeke
Blutdruckinstitut München
Osterwaldstraße 69
80805 München
Phone: 089/36103947
Fax: 089/36104026
URL: http://www.blutdruckinstitut.de
